相关实验视频

Updated: Jul 9, 2025

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

全基因组的元分析和精细映射优先考虑潜在的因果变异和与麻风相关的基因

Zhenzhen Wang^1,2, Tingting Liu², Wenchao Li²

¹Department of Biostatistics School of Public Health Cheeloo College of Medicine Shandong University Jinan Shandong China.

|November 29, 2023

概括

这项研究确定了麻风的新遗传风险位置,精确指出了因果变异和基因. 这些发现提高了对麻风的遗传性和免疫机制的理解.

科学领域:

遗传学遗传学是一个
免疫学免疫学免疫学
流行病学流行病学

背景情况:

全基因组关联研究 (GWAS) 已经确定了35个麻风易感位点,但这些解释了有限的遗传性和缺乏确定的因果变异.
了解麻风的遗传结构对于阐明疾病机制和开发有针对性的干预措施至关重要.

研究的目的:

通过大规模的GWAS元分析,识别出新的麻风病遗传风险位.
精确地绘制已识别的位置,以精确地确定导致变异的因果变体和导致麻风易感性的基因.
调查已识别的变体和基因在麻风病原发生中的功能性作用.

主要方法:

在两个独立的队列中进行了新的GWAS,并对以前发表的数据进行了元分析.
利用全面的精细映射分析来识别因果变异和基因.
整合了表观基因组数据,并进行了基因组,组织和细胞类型丰富分析.

主要成果:

确定了3个新型和15个先前报告的麻风险位,使解释的遗传性从23.0%增加到38.5%.
确定了19种因果变异和14种因果基因,其中变异主要位于免疫调节元件中.
突出了免疫相关组织/细胞和PD-1信号通路在麻风病原发生过程中的参与.

结论:

这项研究显著扩大了已知的麻风病遗传景观.
已识别的候选因果变体和基因提供了有关麻风的监管和编码机制的见解.
这些发现表明,特定的免疫路径和细胞类型与麻风的发展有关,为治疗提供了潜在的点.

关键词:

精细地图绘制 (fine-mapping) 是一种微细地图绘制.全基因组关联研究研究.免疫反应的免疫反应.这是一种麻风病,就是麻风病.路径分析路径分析

更多相关视频

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...